Navigation Links
Genomatix gets patent for comparative genomics method
Date:3/12/2009

Genomatix Software, a company with an outstanding track record in the analysis of genomic data generated by high throughput technologies, announced today that it was issued patent No. EP 1 800 232 B1, "Identification and assignment of functionally corresponding regulatory sequences for orthologous loci in eukaryotic genomes" by the European Patent Office.

The Patent relates to a sophisticated method for identification of networks of functionally related regulatory DNA sequences in different eukaryotic species. With today's high throughput sequencing technology data from an increasing number of various organisms become available. However, the genomic sequence does not reveal scientific insight in the functional organization of the genome. For such the genome needs to be annotated (e.g. location of genes, promoters, genomic repeats etc.). Annotation of regulatory sequences like promoters and enhancers is a special challenge which is not satisfactory solved until today. The patent describes a method using a defined transcriptional start side from a well annotated genome (like human) as an anchor to identify corresponding regulatory regions in the orthologuous areas of less defined species. Results have been proven to be of extremely high quality. Genomatix applies this method in its genomic database ElDorado since several years now and numerous such predicted promoters have been verified experimentally in the meantime.

Dr. Andreas Klingenhoff, Genomatix Head of Genomics and Annotation and the inventor of the approach says: "We developed the method over several years, running many projects aimed to identify the evolutionary conserved regulatory elements shared between different eucaryots. It was essential in understanding regulatory networks, mechanisms and pathways, including disease mechanisms in humans. With increasing insight into the extreme complexity of the transcriptome, the method becomes more and more valuable. We continuously work on further improvements and apply it to an increasing number of species, especially in light with our efforts in next generation sequencing data analysis."


'/>"/>

Contact: Klaus May
may@genomatix.de
49-895-997-660
Genomatix Software GmbH
Source:Eurekalert

Related biology news :

1. CRG buys Genomatix Next Generation Sequencing analysis solution
2. Boehringer Ingelheim uses Genomatix Next Generation Sequencing data analysis systems
3. Genomatix joins Illumina-Connect program
4. Pfizer inks global license to Genomatix Software and databases
5. NIA uses Genomatix in stem cell research, suggests novel transcription factors for stemness
6. BIO-key(R) Granted Patent to Secure Biometric Enrollments From Unauthorized Use
7. BIO-key(R) Granted Additional Patent for Biometric Security Solution
8. LSUHSC awarded patent for compound inhibiting cancer and other diseases
9. Kount Receives Patent for Device Fingerprinting
10. Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology
11. Scripps Research Institute awarded patent for remarkable chemical technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell , ... technology, and STMicroelectronics (NYSE: STM), a global ... electronics applications, announced today the launch of a ... biometric wearables that includes ST,s compact SensorTile ... Benchmark™ biometric sensor system. Together, SensorTile and ...
(Date:12/15/2016)... , December 15, 2016 Arvato ... an agreement with NuData Security, an award-winning international ... will enable clients to focus on good customer experience, balancing ... regulation. ... In order to provide a one-stop fraud prevention suite, Arvato ...
(Date:12/15/2016)... 2016 "Increase in mobile transactions is driving ... biometrics market is expected to grow from USD 4.03 ... at a CAGR of 29.3% between 2016 and 2022. ... growing demand for smart devices, government initiatives, and increasing ... component is expected to grow at a high rate ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... Cleveleys, UK (PRWEB) , ... ... ... results presented by surgeons at the 2016 annual meeting of the North ... beneficial clinical outcomes, for patients in the majority of cases, when PEEK-OPTIMA™ ...
(Date:1/17/2017)... 2017  Protagonist Therapeutics, Inc. (NASDAQ: ... a global Phase 2b induction study in ulcerative ... alpha4beta7 integrin. The aim of this randomized, double-blind, ... safety/tolerability and efficacy of PTG-100 in approximately 240 ... active disease. "We are very ...
(Date:1/16/2017)... 16, 2017  Eurofins Genomics today announced the expansion ... customers to receive their primers in a shorter turnaround ... quality found with other providers. Express oligos are available ... at no additional fee. Researchers use ... including DNA sequencing, genotyping, site-directed mutagenesis, and cloning. Often, ...
(Date:1/13/2017)... ... January 13, 2017 , ... Two ... organic compound called fulvic acid that farms, greenhouses and hydroponics operations use to ... are among the fastest growing segments of customers using this high grade fulvic ...
Breaking Biology Technology: